We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
MLTX icon
151
MoonLake Immunotherapeutics
MLTX
$1.07B
$1.07B $12.60 18.3%
MRVI icon
152
Maravai LifeSciences
MRVI
$1.05B
$1.05B $7.08 6.47%
CTY
153
City Therapeutics, Inc. Common Stock
CTY
$1.03B
$1.03B $20.52 0.44%
JANX icon
154
Janux Therapeutics
JANX
$1.03B
$1.03B $16.85 0.47%
MNKD icon
155
MannKind Corp
MNKD
$1.02B
$1.02B $3.17 3.93%
JBIO icon
156
Jade Biosciences
JBIO
$960M
$960M $15.09 0.26%
CGEM icon
157
Cullinan Oncology
CGEM
$959M
$959M $14.90 0.07%
GLUE icon
158
Monte Rosa Therapeutics
GLUE
$942M
$942M $11.04 1.6%
MGTX icon
159
MeiraGTx Holdings
MGTX
$939M
$939M $9.78 0.81%
AVBP icon
160
ArriVent BioPharma
AVBP
$939M
$939M $19.04 0.42%
SGP icon
161
SpyGlass Pharma
SGP
$931M
$931M $27.84 0.47%
AKTS icon
162
Aktis Oncology
AKTS
$928M
$928M $16.69 1.64%
ODTX icon
163
Odyssey Therapeutics
ODTX
$925M
$925M $19.25 1.32%
SVRA icon
164
Savara
SVRA
$925M
$925M $4.50 3.64%
RIGL icon
165
Rigel Pharmaceuticals
RIGL
$910M
$910M $48.70 0.37%
VSTM icon
166
Verastem
VSTM
$897M
$897M $9.90 7.49%
ANRO icon
167
Alto Neuroscience
ANRO
$884M
$884M $22.53 3.39%
OBX
168
Obsidian Therapeutics
OBX
$883M
$883M $14.29 2.58%
KURA icon
169
Kura Oncology
KURA
$880M
$880M $9.89 0.1%
ALMS icon
170
Alumis Inc
ALMS
$879M
$879M $6.79 0.29%
CRVS icon
171
Corvus Pharmaceuticals
CRVS
$873M
$873M $10.38 3.28%
IVA icon
172
Inventiva
IVA
$846M
$846M $3.58 0.85%
ABUS icon
173
Arbutus Biopharma
ABUS
$834M
$834M $4.21 0.72%
ARDX icon
174
Ardelyx
ARDX
$826M
$826M $3.20 2.24%
HELP
175
Helus Pharma Inc. Common Stock
HELP
$772M
$772M $10.56 2.04%
5 6
7
8 9

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.25T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $136B, Regeneron Pharmaceuticals (REGN) at $84.5B and Moderna (MRNA) at $74.4B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.